Topical Retinoids Versus Benzoyl Peroxide in Acne Maintenance Therapy: Comparative Role, Evidence, And Practical Use
Main Article Content
Abstract
Acne vulgaris is a chronic inflammatory disorder with a high tendency for relapse after initial improvement. Maintenance therapy is therefore essential to prevent recurrence, reduce new lesion formation, minimize scarring, and maintain long-term disease control. Topical retinoids and benzoyl peroxide are two major non-antibiotic agents used in acne treatment, but they have different roles in maintenance. Topical retinoids are generally considered the core maintenance therapy because they target microcomedone formation, normalize follicular keratinization, and prevent the development of both comedonal and inflammatory lesions. Benzoyl peroxide provides antimicrobial and anti-inflammatory activity without inducing bacterial resistance and is especially useful when inflammatory relapse remains a concern. However, benzoyl peroxide alone is less often positioned as the primary long-term maintenance agent compared with topical retinoids. Current evidence suggests that retinoid–benzoyl peroxide combinations may offer the strongest relapse prevention, particularly in patients with moderate-to-severe acne, recent isotretinoin therapy, or high risk of recurrence. This review compares topical retinoids and benzoyl peroxide for acne maintenance, emphasizing mechanism of action, efficacy, tolerability, relapse prevention, combination therapy, and practical selection.
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Leung AKC, Barankin B, Lam JM, Leong KF, Hon KL. Dermatology: how to manage acne vulgaris. Drugs Context. 2021;10. doi:10.7573/dic.2021-8-6
II. Bettoli V, Borghi A, Zauli S, Toni G, Ricci M, Giari S, Virgili A. Maintenance therapy for acne vulgaris: efficacy of a 12-month treatment with adapalene-benzoyl peroxide after oral isotretinoin and a review of the literature. Dermatology. 2013;227:97-102. doi:10.1159/000350820
III. Leyden J. Recent advances in the use of adapalene 0.1%/benzoyl peroxide 2.5% to treat patients with moderate to severe acne. J Dermatolog Treat. 2016;27:S13-S14. doi:10.3109/09546634.2016.1145338
IV. Emmerich V, Purvis C, Feldman S. An overview of adapalene and benzoyl peroxide once-daily topical gel as a therapeutic option for acne. Expert Opin Pharmacother. 2021;22:1661-1667. doi:10.1080/14656566.2021.1939678
V. Ullah A, Muhammad A, Mehmood F, Farooq H, Ahmad B, Haq AB, et al. Comparing the efficacy of topical 4% benzoyl peroxide versus topical 0.1% adapalene for treatment of acne vulgaris in skin of color population: a South Asian perspective. Cureus. 2024;16:e55555. doi:10.7759/cureus.55555
VI. Fahim B, Shaikh MA, Ejaz T, Batool P. Evaluating topical treatments for mild to moderate acne: a cross-sectional study. Ukr J Med Biol Sport. 2024. doi:10.63341/ujmbs/4.2024.016
VII. Aschoff R, Möller S, Haase R, Kuske M. Tolerability and efficacy of clindamycin/tretinoin versus adapalene/benzoyl peroxide in the treatment of acne vulgaris. J Drugs Dermatol. 2021;20:295-301. doi:10.36849/JDD.2021.5641
VIII. Mavranezouli I, Daly C, Welton N, Deshpande S, Berg L, Bromham N, et al. A systematic review and network meta-analysis of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris. Br J Dermatol. 2022;187:639-649. doi:10.1111/bjd.21739
IX. Reynolds RV, Yeung H, Cheng CE, Cook-Bolden F, Desai S, Druby K, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024. doi:10.1016/j.jaad.2023.12.017
X. Sattar K, Sakina S, Mumtaz S, Behram F, Akbar A, Jadoon SK, Tasneem S. Safety and efficacy of fixed-dose combination of adapalene and benzoyl peroxide in acne vulgaris treatment: a systematic review of clinical trials. Cureus. 2024;16:e69341. doi:10.7759/cureus.69341